News & Events Navigating USP <382>: Ensuring Functional Suitability in Pharmaceutical Packaging The upcoming changes to USP <382>... adminApr 2, 2025Apr 2, 2025
News & Events Examining the Intricacies of Particulate Matter Analysis in Pharmaceuticals The characterization and analysis of particulate... adminMar 20, 2025Mar 20, 2025
News & Events What Changes Are Happening to USP <382> in December 2025? In December 2025, significant changes will... adminMar 5, 2025Mar 5, 2025
News & Events Particulate Matter Characterization in Pharmaceuticals Characterizing particulate matter in pharmaceuticals is... adminFeb 19, 2025Feb 19, 2025
News & Events Understanding the Scope and Impact of USP <382> on Pharmaceutical Packaging and Delivery Systems USP <382> Pharmaceutical Packaging: Ensuring Safety... adminJan 28, 2025Feb 7, 2025
News & Events Mastering Source Determination: A Critical Step in Particulate Matter Control for Therapeutic Development When it comes to therapeutics development,... adminJan 15, 2025Jan 15, 2025
News & Events Wishing You Very Happy Holidays from Gateway Analytical! Looking Ahead: Participation in Key Industry... adminDec 29, 2024Dec 31, 2024
News & Events Source Identification: Particulate Matter Control Solutions for Pharmaceuticals In our industry, controlling particulate contamination... adminDec 2, 2024Dec 2, 2024
News & Events Exploring Functional Suitability & Package/Delivery System Integrity (USP 382 & USP 1207) Container closure integrity (CCI) is a... adminNov 19, 2024Nov 19, 2024
News & Events Particulate Matter in Cell Therapies: A Critical Step Forward Cell therapy developers have reached a... adminNov 11, 2024Nov 11, 2024